These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28700700)

  • 1. The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice.
    McDonnell C; Leánez S; Pol O
    PLoS One; 2017; 12(7):e0180998. PubMed ID: 28700700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice.
    McDonnell C; Leánez S; Pol O
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29143802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antinociceptive effects of a δ-opioid receptor agonist in mice with painful diabetic neuropathy: Involvement of heme oxygenase 1.
    Castany S; Carcolé M; Leánez S; Pol O
    Neurosci Lett; 2016 Feb; 614():49-54. PubMed ID: 26762785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin.
    Okura T; Cowell SM; Varga E; Burkey TH; Roeske WR; Hruby VJ; Yamamura HI
    Eur J Pharmacol; 2000 Jan; 387(2):R11-3. PubMed ID: 10650167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
    Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
    Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-specific down-regulation of the human delta-opioid receptor.
    Okura T; Varga EV; Hosohata Y; Navratilova E; Cowell SM; Rice K; Nagase H; Hruby VJ; Roeske WR; Yamamura HI
    Eur J Pharmacol; 2003 Jan; 459(1):9-16. PubMed ID: 12505529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane protects against skeletal muscle dysfunction in spontaneous type 2 diabetic db/db mice.
    Wang M; Pu D; Zhao Y; Chen J; Zhu S; Lu A; Liao Z; Sun Y; Xiao Q
    Life Sci; 2020 Aug; 255():117823. PubMed ID: 32445760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of heme oxygenase 1 in the molecular changes and neuropathy associated with type 2 diabetes in mice.
    Pouso-Vázquez E; Bai X; Batallé G; Roch G; Pol O
    Biochem Pharmacol; 2022 May; 199():114987. PubMed ID: 35276215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes.
    Negi G; Kumar A; Sharma SS
    Curr Neurovasc Res; 2011 Nov; 8(4):294-304. PubMed ID: 22023613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation S363A in the human delta-opioid receptor selectively reduces down-regulation by a peptide agonist.
    Navratilova E; Varga EV; Stropova D; Jambrosic JC; Roeske WR; Yamamura HI
    Eur J Pharmacol; 2004 Feb; 485(1-3):341-3. PubMed ID: 14757159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins.
    Lecoq I; Marie N; Jauzac P; Allouche S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):666-77. PubMed ID: 15102931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice.
    Hervera A; Leánez S; Negrete R; Pol O
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):345-52. PubMed ID: 19636536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
    Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
    Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with Sulforaphane Produces Antinociception and Improves Morphine Effects during Inflammatory Pain in Mice.
    Redondo A; Chamorro PAF; Riego G; Leánez S; Pol O
    J Pharmacol Exp Ther; 2017 Dec; 363(3):293-302. PubMed ID: 28947488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel
    Meqbil YJ; Aguilar J; Blaine AT; Chen L; Cassell RJ; Pradhan AA; van Rijn RM
    J Pharmacol Exp Ther; 2024 May; 389(3):301-309. PubMed ID: 38621994
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice.
    Ferreira-Chamorro P; Redondo A; Riego G; Leánez S; Pol O
    Front Pharmacol; 2018; 9():1332. PubMed ID: 30542282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.
    Pu D; Zhao Y; Chen J; Sun Y; Lv A; Zhu S; Luo C; Zhao K; Xiao Q
    Neuroscience; 2018 Jun; 381():35-45. PubMed ID: 29684505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Induction of Heme Oxygenase 1 Decreases Painful Diabetic Neuropathy and Enhances the Antinociceptive Effects of Morphine in Diabetic Mice.
    Castany S; Carcolé M; Leánez S; Pol O
    PLoS One; 2016; 11(1):e0146427. PubMed ID: 26730587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells.
    Wallace DR; Dodson SL; Nath A; Booze RM
    Neurotoxicology; 2006 Jan; 27(1):101-7. PubMed ID: 16168488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.